George Frangeskides, Exec-Chair at Alba Mineral Resources, discusses grades at the Clogau Gold Mine. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,706.20
Bid: 1,705.60
Ask: 1,706.20
Change: 1.00 (0.06%)
Spread: 0.60 (0.035%)
Open: 1,701.60
High: 1,708.60
Low: 1,699.40
Prev. Close: 1,705.20
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2 Mar 2023 07:00

US FDA panel supports GSK vaccine ahead of approval decision

(Alliance News) - GSK PLC on Wednesday said the US Food & Drug Administration's advisory committee voted to support its respiratory syncytial virus vaccine candidate for older adults.

Read more
2 Mar 2023 06:56

LONDON MARKET EARLY CALL: Stocks called higher; pound below USD1.20

(Alliance News) - Stocks in London are set to open higher on Thursday, ahead of a eurozone inflation reading.

Read more
27 Feb 2023 09:26

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
24 Feb 2023 15:20

Flu experts gather with H5N1 risk on the agenda

LONDON, Feb 24 (Reuters) - The world's leading experts on influenza met this week to discuss the threat posed to humans by a strain of H5N1 avian flu that has caused record numbers of bird deaths around the world in recent months.

Read more
24 Feb 2023 15:10

First Zantac cancer risk trial in Calif. postponed five months

Feb 23 (Reuters) - The first scheduled trial over claims that GSK Plc's heartburn drug Zantac caused cancer, which had been set to begin Monday, has been postponed by five months.

Read more
24 Feb 2023 06:00

Flu experts gather with H5N1 risk on the agenda

LONDON, Feb 24 (Reuters) - The world's leading experts on influenza met this week to discuss the threat posed to humans by a strain of H5N1 avian flu that has caused record numbers of bird deaths around the world in recent months.

Read more
23 Feb 2023 17:22

Upbeat corporate guidances lift European shares, Nvidia forecast boosts chip stocks

UK healthcare giants fall on ex-dividend trades

*

Read more
23 Feb 2023 17:10

FTSE 100 slips as ex-dividend trades weigh, Rolls-Royce soars

Rolls-Royce jumps on upbeat forecast

*

Read more
23 Feb 2023 17:00

LONDON MARKET CLOSE: FTSE 100 struggles, but European peers rise

(Alliance News) - Stock prices in London closed mixed on Thursday, with blue-chips ending in the red on renewed concerns of higher rates in the US, as well as a host of stocks going ex-dividend.

Read more
23 Feb 2023 09:02

GSK, Pfizer venture says HIV injectable therapy preferred in trial

(Alliance News) - GSK PLC on Thursday said that ViiV Healthcare has found that its injectable Cabenuva is as effective as the daily oral Biktarvy in treating HIV-1.

Read more
23 Feb 2023 08:11

GSK's ViiV says trial indicates HIV shot as effective as rival Gilead pill

(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.

Read more
22 Feb 2023 16:00

GSK's ViiV says study shows its long-acting HIV shot as effective as Gilead's daily pill

LONDON, Feb 22 (Reuters) - British drugmaker GSK's HIV treatment division, ViiV Healthcare, published data on Wednesday showing its long-acting HIV injection is as effective as the market-leading daily pill made by Gilead Sciences Inc.

Read more
22 Feb 2023 13:13

GSK, Pfizer joint venture gets EU marketing approval for HIV treatment

(Alliance News) - ViiV Healthcare on Wednesday said it received marketing authorisation from the European Commission for Triumeq PD, a treament for children living with HIV

Read more
16 Feb 2023 23:17

Judge weighs key evidence ahead of first Zantac cancer trial

Feb 16 (Reuters) - Lawyers for a man who alleges he developed bladder cancer after taking GSK Plc's heartburn drug Zantac urged a California judge on Thursday to allow expert testimony linking the drug to the illness at an upcoming trial.

Read more
16 Feb 2023 19:38

Judge to weigh key evidence ahead of first Zantac cancer trial

Feb 16 (Reuters) - GSK Plc is expected to urge a California judge on Thursday to limit what expert testimony jurors can hear in the first trial over claims that the company's heartburn drug Zantac caused cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.